Company: NCEL
Filing Date: 2025-01-31
Form Type: 6-K
Source: 0001213900-25-008826
Chunk: 3

Company: NewcelX Ltd.
Filing Date: 2025-01-31
Form: 6-K
Chunk 3
---
 sources indicated
above.

This
Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3
(File Nos. 333-282788, 333-262489, 333-268690 and 333-269220), filed with the Securities and Exchange Commission, to be
a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed
or furnished.

<div align='center'>EXHIBIT INDEX</div>

<div align='center'>2

SIGNATURES</div>

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

| Date: January 31, 2025 | NLS Pharmaceutics Ltd. 
 By:                    | /s/ Alexander Zwyer |                         |
|:-----------------------|:-----------------------|:--------------------|:------------------------|
|                        |                        | Name:               | Alexander Zwyer         |
|                        |                        | Title:              | Chief Executive Officer |

<div align='center'>3</div>